250 related articles for article (PubMed ID: 31077555)
1. A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.
Hoff U; Bubalo G; Fechner M; Blum M; Zhu Y; Pohlmann A; Hentschel J; Arakelyan K; Seeliger E; Flemming B; Gürgen D; Rothe M; Niendorf T; Manthati VL; Falck JR; Haase M; Schunck WH; Dragun D
Acta Physiol (Oxf); 2019 Oct; 227(2):e13297. PubMed ID: 31077555
[TBL] [Abstract][Full Text] [Related]
2. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
[TBL] [Abstract][Full Text] [Related]
3. Epoxide metabolites of arachidonate and docosahexaenoate function conversely in acute kidney injury involved in GSK3β signaling.
Deng BQ; Luo Y; Kang X; Li CB; Morisseau C; Yang J; Lee KSS; Huang J; Hu DY; Wu MY; Peng A; Hammock BD; Liu JY
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12608-12613. PubMed ID: 29109264
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
Hoff U; Lukitsch I; Chaykovska L; Ladwig M; Arnold C; Manthati VL; Fuller TF; Schneider W; Gollasch M; Muller DN; Flemming B; Seeliger E; Luft FC; Falck JR; Dragun D; Schunck WH
Kidney Int; 2011 Jan; 79(1):57-65. PubMed ID: 20962739
[TBL] [Abstract][Full Text] [Related]
5. Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.
Nithipatikom K; Moore JM; Isbell MA; Falck JR; Gross GJ
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H537-42. PubMed ID: 16473964
[TBL] [Abstract][Full Text] [Related]
6. Ophiopogonin D Reduces Myocardial Ischemia-Reperfusion Injury via Upregulating CYP2J3/EETs in Rats.
Huang X; Wang Y; Wang Y; Yang L; Wang J; Gao Y
Cell Physiol Biochem; 2018; 49(4):1646-1658. PubMed ID: 30227401
[TBL] [Abstract][Full Text] [Related]
7. Epoxyeicosatrienoic acid analogue mitigates kidney injury in a rat model of radiation nephropathy.
Hye Khan MA; Fish B; Wahl G; Sharma A; Falck JR; Paudyal MP; Moulder JE; Imig JD; Cohen EP
Clin Sci (Lond); 2016 Apr; 130(8):587-99. PubMed ID: 26772189
[TBL] [Abstract][Full Text] [Related]
8. Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.
Muroya Y; Fan F; Regner KR; Falck JR; Garrett MR; Juncos LA; Roman RJ
J Am Soc Nephrol; 2015 Oct; 26(10):2460-9. PubMed ID: 25644108
[TBL] [Abstract][Full Text] [Related]
9. Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury.
Chen L; Markó L; Kaßmann M; Zhu Y; Wu K; Gollasch M
PLoS One; 2014; 9(10):e109842. PubMed ID: 25330307
[TBL] [Abstract][Full Text] [Related]
10. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
Imig JD
Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
[TBL] [Abstract][Full Text] [Related]
11. Orally active epoxyeicosatrienoic acid analog does not exhibit antihypertensive and reno- or cardioprotective actions in two-kidney, one-clip Goldblatt hypertensive rats.
Alánová P; Husková Z; Kopkan L; Sporková A; Jíchová Š; Neckář J; Imig JD; Klevstig M; Kolář F; Rami Reddy N; Falck JR; Sadowski J; Nishiyama A; Kramer HJ; Melenovský V; Červenková L; Kujal P; Vernerová Z; Červenka L
Vascul Pharmacol; 2015 Oct; 73():45-56. PubMed ID: 26304700
[TBL] [Abstract][Full Text] [Related]
12. Determination of cytochrome P450 metabolites of arachidonic acid in coronary venous plasma during ischemia and reperfusion in dogs.
Nithipatikom K; DiCamelli RF; Kohler S; Gumina RJ; Falck JR; Campbell WB; Gross GJ
Anal Biochem; 2001 May; 292(1):115-24. PubMed ID: 11319825
[TBL] [Abstract][Full Text] [Related]
13. CYP2J2-produced epoxyeicosatrienoic acids attenuate ischemia/reperfusion-induced acute kidney injury by activating the SIRT1-FoxO3a pathway.
Zhu Y; Ding A; Yang D; Cui T; Yang H; Zhang H; Wang C
Life Sci; 2020 Apr; 246():117327. PubMed ID: 31954161
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 and arachidonic acid metabolites: role in myocardial ischemia/reperfusion injury revisited.
Gross GJ; Falck JR; Gross ER; Isbell M; Moore J; Nithipatikom K
Cardiovasc Res; 2005 Oct; 68(1):18-25. PubMed ID: 15993870
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis repressor with caspase recruitment domain deficiency accelerates ischemia/reperfusion (I/R)-induced acute kidney injury by suppressing inflammation and apoptosis: The role of AKT/mTOR signaling.
Yingjie K; Haihong Y; Lingwei C; Sen Z; Yuanting D; Shasha C; Liutong P; Ying W; Min Z
Biomed Pharmacother; 2019 Apr; 112():108681. PubMed ID: 30970510
[TBL] [Abstract][Full Text] [Related]
16. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
Imig JD
Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
[TBL] [Abstract][Full Text] [Related]
17. Orally Active Epoxyeicosatrienoic Acid Analogs.
Campbell WB; Imig JD; Schmitz JM; Falck JR
J Cardiovasc Pharmacol; 2017 Oct; 70(4):211-224. PubMed ID: 28937442
[TBL] [Abstract][Full Text] [Related]
18. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Motoki A; Merkel MJ; Packwood WH; Cao Z; Liu L; Iliff J; Alkayed NJ; Van Winkle DM
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2128-34. PubMed ID: 18835921
[TBL] [Abstract][Full Text] [Related]
20. The protective effect of epoxyeicosatrienoic acids on cerebral ischemia/reperfusion injury is associated with PI3K/Akt pathway and ATP-sensitive potassium channels.
Qu YY; Yuan MY; Liu Y; Xiao XJ; Zhu YL
Neurochem Res; 2015 Jan; 40(1):1-14. PubMed ID: 25366463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
